Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inmed Pharmaceuticals Inc SUITE 310 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 CAN

www.inmedpharma.com P: 604-669-7207 F: 778-945-6800

Description:

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

Key Statistics

Overview:

Market Capitalization, $K 1,526
Enterprise Value, $K -7,384
Shares Outstanding, K 6,057
Annual Sales, $ 4,140 K
Annual Net Income, $ -7,950 K
Last Quarter Sales, $ 1,240 K
Last Quarter Net Income, $ -1,480 K
EBIT, $ -6,780 K
EBITDA, $ -6,580 K
60-Month Beta 0.10
% of Insider Shareholders 1.39%
% of Institutional Shareholders 20.12%
Float, K 5,973
% Float 98.61%
Short Volume Ratio 0.43

Growth:

1-Year Return -80.83%
3-Year Return -99.75%
5-Year Return -99.92%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 02/13/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.55
EPS Growth vs. Prev Qtr 75.00%
EPS Growth vs. Prev Year 79.12%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 09/07/22

INM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.31%
Return-on-Assets % -46.23%
Profit Margin % -192.03%
Debt/Equity 0.00
Price/Sales 0.44
Price/Cash Flow N/A
Price/Book 0.12
Book Value/Share 2.25
Interest Coverage -0.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar